164 related articles for article (PubMed ID: 15746740)
1. Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis).
Kaulitz R; Ziemer G; Rauch R; Girisch M; Bertram H; Wessel A; Hofbeck M
J Thorac Cardiovasc Surg; 2005 Mar; 129(3):569-75. PubMed ID: 15746740
[TBL] [Abstract][Full Text] [Related]
2. Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure.
Cheung YF; Chay GW; Chiu CS; Cheng LC
Int J Cardiol; 2005 Jul; 102(3):509-13. PubMed ID: 16004898
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic problems after the Fontan operation.
Monagle P; Karl TR
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():36-47. PubMed ID: 11994863
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
Monagle P; Cochrane A; Roberts R; Manlhiot C; Weintraub R; Szechtman B; Hughes M; Andrew M; McCrindle BW;
J Am Coll Cardiol; 2011 Aug; 58(6):645-51. PubMed ID: 21798429
[TBL] [Abstract][Full Text] [Related]
5. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
6. Outcome of 200 patients after an extracardiac Fontan procedure.
Kim SJ; Kim WH; Lim HG; Lee JY
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):108-16. PubMed ID: 18603062
[TBL] [Abstract][Full Text] [Related]
7. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches.
Seipelt RG; Franke A; Vazquez-Jimenez JF; Hanrath P; von Bernuth G; Messmer BJ; Mühler EG
Ann Thorac Surg; 2002 Aug; 74(2):556-62. PubMed ID: 12173844
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of patients 20 years after Fontan operation--effect of fenestration on late morbidity.
Ono M; Boethig D; Goerler H; Lange M; Westhoff-Bleck M; Breymann T
Eur J Cardiothorac Surg; 2006 Dec; 30(6):923-9. PubMed ID: 17074498
[TBL] [Abstract][Full Text] [Related]
10. Early anticoagulation after mechanical valve implantation, and related complications.
Puri D; Kumar A; Basu R; Chaudhary A; Sarwal V; Sahoo M; Mahant TS
J Heart Valve Dis; 2008 Jul; 17(4):418-24; discussion 425. PubMed ID: 18751472
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted?
Koya MP; Manoharan M; Kim SS; Soloway MS
BJU Int; 2005 Nov; 96(7):1019-21. PubMed ID: 16225520
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliation.
Potter BJ; Leong-Sit P; Fernandes SM; Feifer A; Mayer JE; Triedman JK; Walsh EP; Landzberg MJ; Khairy P
Int J Cardiol; 2013 Oct; 168(4):3940-3. PubMed ID: 23870650
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of haemostatic complications in 412 Fontan patients: their relation to anticoagulation and haemodynamics.
Ohuchi H; Yasuda K; Miyazaki A; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Yamada O
Eur J Cardiothorac Surg; 2015 Mar; 47(3):511-9. PubMed ID: 24699205
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
15. No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.
Iyengar AJ; Winlaw DS; Galati JC; Wheaton GR; Gentles TL; Grigg LE; Justo RN; Radford DJ; Attard C; Weintraub RG; Bullock A; Sholler GS; Celermajer DS; d'Udekem Y;
Eur J Cardiothorac Surg; 2016 Nov; 50(5):980-987. PubMed ID: 27229665
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
Keeney JA; Clohisy JC; Curry MC; Maloney WJ
J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
[TBL] [Abstract][Full Text] [Related]
17. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.
Mahnke CB; Boyle GJ; Janosky JE; Siewers RD; Pigula FA
Pediatr Cardiol; 2005; 26(1):56-61. PubMed ID: 14994183
[TBL] [Abstract][Full Text] [Related]
19. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
McCrindle BW; Manlhiot C; Cochrane A; Roberts R; Hughes M; Szechtman B; Weintraub R; Andrew M; Monagle P;
J Am Coll Cardiol; 2013 Jan; 61(3):346-53. PubMed ID: 23246393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
